Abstract
Metastatic Lewis lung carcinoma (LLC-LN7) tumors that secrete granulocyte/macrophage-colonystimulating factor (GM-CSF) stimulate myelopoiesis and induce bone marrow-derived immunosuppressor cells that are homologous to granulocyte/macrophage progenitor cells. In vitro treatment of the LLC-LN7 cells with 1α,25-dihydroxyvitamin D3 reduced tumor cell production of suppressor-inducing activity, although suppressor-inducing activity could be restored by reconstituting the tumor supernatants with recombinant GM-CSF. Treatment of mice having LLC-LN7 tumors with vitamin D3 reduced tumor production of GM-CSF and the frequency of myeloid progenitor cells. This was associated with a reduction in immunosuppressor activity and an increase in T cell function. Vitamin D3 treatment of mice having palpable tumors transiently retarded tumor growth, but caused a prominent reduction in tumor metastasis. Treating mice with vitamin D3 after tumor excision resulted in a reduction in the tumor-induced myelopoietic stimulation and associated immunosuppressive activity, and enhanced T cell function. These mice had a markedly reduced incidence of tumor recurrence. The results of this study suggest that vitamin D3 treatment of mice with GM-CSF-secreting tumors can interrupt the myelopoiesis-associated immunosuppressor cascade and, in turn, reduce tumor metastasis and recurrence.
Similar content being viewed by others
References
Vujanovic NL, Yasumura S, Hirabayashi H, Lin W, Watkins S, Herberman RB, Whiteside TL (1995) Antitumor activities of subsets of human IL-2-activated natural killer cells in solid tissues. J Immunol 154:281
Matsumura T, Sussman JJ, Krinock RA, Chang AE, Shu S (1994) Characteristics and vn vivo homing of long-term T-cell lines and clones derived from tumor-draining lymph nodes. Cancer Res 54:2744
Alexander JP, Kudoh S, Melsop KA, Hamilton TA, Edinger MG, Tubbs RR, Sica D, Tuason L, Klein E, Budowski RM, Finke JH (1993) T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors. Cancer Res 53:1380
Alleva DG, Burger CJ, Elgert KD (1994) Tumour growth causes suppression of autoreactive T-cell proliferation by disrupting macrophage responsiveness to interferon-gamma. Scand J Immunol 39:31
Mizoguchi H, O'Shea JJ, Longo DL, Loeffler CM, Mc Vicar DW, Ochoa AC (1992) Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science 258:1795
Walker TM, Burger CJ, Elgert KD (1994) Tumor growth alters T cell and macrophage production of and responsiveness to granulocyte-macrophage colony-stimulating factor: partial dysregulation through interleukin-10. Cell Immunol 154:342
O'Mahony AM, O'Sullivan GC, O'Connell J, Cotter TG, Collins JK (1993) An immune suppressive factor derived from esophageal squamous carcinoma induces apoptosis in normal and transformed cells of lymphoid lineage. J Immunol 151:4847
Young MRI (1994) Eicosanoids and the immunology of cancer. Cancer Metastasis Rev 13:337
Alleva DG, Burger CJ, Elgert KD (1994) Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-α production: role of tumor-derived IL-10, TGF-β, and prostaglandin E2. J Immunol 153:1674
Inge TH, Hoover SK, Frank JL, Kawabata TT, Bethke KP, Bear HD (1992) Enhancement of cytotoxic T lymphocyte growth from spleens of P815-tumor-bearing host mice with mafosfamide. Cancer Immunol Immunother 35:119
Tepper RI, Mule JJ (1994) Experimental and clinical studies of cytokine gene-modified tumor cells. Human Gene Ther 5:153
Dranoff G, Jaffee E, Lazenby A, Golumbek P, Levitsky H, Brose K, Jackson V, Hamada H, Pardoll D, Mulligan RC (1993) Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA 90:3539
Levitsky HI, Lazenby A, Hayashi RJ, Pardoll DM (1994) In vivo priming of two distinct antitumor effector populations: the role of MHC class I expression. J Exp Med 179:1215
Allione A, Consalvo M, Nanni P, Lollini PL, Cavallo F, Giovarelli M, Forni M, Gulino A, Colombia MP, Dellabona P, Hock H, Blankenstein T, Rosenthal FM, Gansbacher B, Bosco MC, Musso T, Gusella L, Forni G (1994) Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor α, granulocyte-macrophage colony-stimulating factor, and γ-interferon gene or admixed with convectional adjuvants. Cancer Res 54:6022
Young MRI, Schmidt-Pak A, Wright MA, Matthews JP, Collins SL, Petruzzelli G (1995) Mechanisms of immune suppression in patients with head and neck cancer: presence of immune suppressive CD34+ cells in cancers that secrete granulocyte-macrophage colony-stimulating factor. Clin Cancer Res 1:95
Lang SH, Miller WR, Duncan W, Habib FK (1994) Production and response of human prostate cancer cell lines to granulocyte macrophage-colony stimulating factor. Int J Cancer 59:235
Oghiso Y, Yamada Y, Ando K, Ishihara H, Shibata Y (1993) Differential induction of prostaglandin E2-dependent and-independent immune suppressor cells by tumor-derived GM-CSF and M-CSF. J Leukoc Biol 53:86
Young MRI, Halpin J, Wang J, Wright MA, Matthews J, Schmidt-Pak A (1993) 1α,25-dihydroxyvitamin D3 plus γ-interferon blocks lung tumor production of granulocyte-macrophage colony-stimulating factor and induction of immunosuppressor cells. Cancer Res 53:6006
Hoskin DW, Bowser DA, Brooks-Kaiser JC (1992) Soybean agglutinin-positive natural suppressor cells in mouse bone marrow inhibit interleukin 2 production and utilization in mixed lymphocyte reactions. J Leukoc Biol 51:649
Moore SC, Shaw MA, Soderberg SF (1992) Transforming growth factor-β is the major mediator of natural suppressor cells derived from normal bone marrow. J Leukoc Biol 52:596
Schmidt-Wolf IG, Dejbakhsh-Jones S, Ginzton N, Greenberg P, Strober S (1992) T-cell subsets and suppressor cells in human bone marrow. Blood 80:3242
Sigiura K, Ikeara S, Inaba M, Haraguchi S, Ogata H, Sardina EE, Sugawara M, Ohta Y, Good RA (1992) Enrichment of murine bone marrow natural suppressor activity in the fraction of hematopoietic progenitors with interleukin 3 receptor-associated antigen. J Exp Hematol 20:256
Young MRI, McCloskey G, Wright MA, Schmidt Pak A (1994) Increasing infiltration and activation of CD8+ tumor-infiltrating lymphocytes after eliminating immune suppressive granulocyte-macrophage progenitor cells with low doses of interferon-γ plus tumor necrosis factor-α. Cancer Immunol Immunother 38:9
Young MRI, Wright MA (1992) Myelopoiesis-associated immune suppressor cells in mice bearing metastatic Lewis lung carcinoma tumors: interferon-γ plus tumor necrosis factor-α synergistically reduce immune suppressor and tumor growth-promoting activities of bone marrow cells, and diminish tumor recurrence and metastasis. Cancer Res 52:6335
Young MR, Aquino S, Young ME (1989) Differential induction of hematopoiesis and immune suppressor cells in the bone marrow versus in the spleen by Lewis lung carcinoma variants. J Leukoc Biol 45:262
Schmidt-Pak A, Ip G, Wright MA, Young MRI (1995) Treating tumor-bearing mice with low dose interferon-γ plus tumor necrosis factor-α to diminish immune suppressive granulocytemacrophage progenitor cells increases responsiveness to IL-2 immunotherapy. Cancer Res (in press)
Young MRI, Wright MA, Coogan M, Young ME, Bagash J (1992) Tumor-derived cytokines induce bone marrow suppressor cells that mediate immunosuppression through transforming growth factor β. Cancer Immunol Immunother 35:14
Tobler A, Marti H-P, Gimmi C, Cachelin AB, Saurer S, Fey MF (1991) Dexamethasone and 1,25-dihydroxyvitamin D3, but not cyclosporine A, inhibit production of granulocyte-macrophage colony-stimulating factor in human fibroblasts. Blood 77:1912
Mathieu C, Laureys J, Sobis H, Vandeputte M, Waer M, Bouillon R (1992) 1,25-Dihydroxyvitamin D3 prevents insulitis in NOD mice. Diabetes 41:1491
Lemire JM, Archer DC (1991) 1,25-Dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J Clin Invest 87:1103
Young MRI, Wright MA, Young ME (1991) Antibodies to colony-stimulating factors block Lewis lung carcinoma cell-stimulation of immune suppressive bone marrow cells. Cancer Immunol Immunother 33:146
Young MRI, Young ME, Wright MA (1990) Myelopoiesis-associated suppressor cell activity in mice with Lewis lung carcinoma tumors: interferon-γ plus tumor necrosis factor-α synergistically reduce suppressor cell activity. Int J Cancer 46:245
Tsuchiya Y, Igarashi M, Suzuki R, Kumagai K (1988) Production of colony-stimulating factor by tumor cells and the factor-mediated induction of suppressor cells. J Immunol 141:699
O'Reilly M, Silver GM, Gamelli RL, Davis JH, Hebert JC (1994) Dose dependency of granulocyte-macrophage colony stimulating factor for improving survival following burn wound infection. J Trauma 36:486
Seres I, Csongor J, Mohacsi A, Leovey A, Fulop T (1993) Age-dependent alterations of human recombinant GM-CSF effects on human granulocytes. Mech Ageing Dev 71:143
Walker TM, Yurochko AD, Burger CJ, Elgert KD (1992) Tumor growth changes the contribution of granulocyte-macrophage colony-stimulating factor during macrophage-mediated suppression of allorecognition. Immunobiology 185:427
Fu Y-X, Watson GA, Kasahara M, Lopez DM (1991) The role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. I. Induction of regulatory macrophages in normal mice by the in vivo administration of rGM-CSF. J Immunol 146:783
Hernandez-Frontera E, McMurray DN (1993) Dietary vitamin D affects cell-mediated hypersensitivity but not resistance to experimental pulmonary tuberculosis in guinea pigs. Infect Immun 61:2116
Lacey DL, Erdmann JM, Tan HL (1993) 1,25-Dihydroxyvitamin D3 increases type 1 interleukin-1 receptor expression in a murine T cell line. J Cell Biochem 52:159
Lemire JM (1992) Immunomodulatory role of 1,25-dihydroxyvitamin D3. J Cell Biochem 49:26
Manolagas SC, Yu XP, Girasole G, Bellido T (1993) Vitamin D and the hematolymphopoietic tissue: a 1994 update. Semin Nephrol 14:129
Shabahang M, Buras RR, Davoodi F, Schumaker LM, Nauta RJ, Uskokovic MR, Brenner RV, Evans SRT (1994) Growth inhibition of HT-29 human colon cancer cells by analogues of 1, 25-dihydroxyvitamin D3. Cancer Res 54:4057
Colston KW, Makay AG, James SY, Binderup L, Chander S, Coombes RC (1992) EB1089: a new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro. Biochem Pharmacol 44:2273
Author information
Authors and Affiliations
Additional information
This study was supported in part by grants from the Medical Research Service of the Department of Veterans Affairs and by grants CA-45080 and CA-48080 from the National Institutes of Health
Rights and permissions
About this article
Cite this article
Young, M.R.I., Ihm, J., Lozano, Y. et al. Treating tumor-bearing mice with vitamin D3 diminishes tumor-induced myelopoiesis and associated immunosuppression, and reduces tumor metastasis and recurrence. Cancer Immunol Immunother 41, 37–45 (1995). https://doi.org/10.1007/BF01788958
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01788958